Free Trial

Tissue Regenix Group (TRX) Competitors

Tissue Regenix Group logo
GBX 25 -0.50 (-1.96%)
As of 09/12/2025 11:35 AM Eastern

TRX vs. NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, WPM, and IAG

Should you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), Wheaton Precious Metals (WPM), and International Consolidated Airlines Group (IAG). These companies are all part of the "precious metals" industry.

Tissue Regenix Group vs. Its Competitors

Tissue Regenix Group (LON:TRX) and Nakama Group plc (NAK.L) (LON:NAK) are both small-cap precious metals companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

In the previous week, Tissue Regenix Group's average media sentiment score of 0.00 equaled Nakama Group plc (NAK.L)'saverage media sentiment score.

Company Overall Sentiment
Tissue Regenix Group Neutral
Nakama Group plc (NAK.L) Neutral

Nakama Group plc (NAK.L) has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Nakama Group plc (NAK.L)'s return on equity of 0.00% beat Tissue Regenix Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tissue Regenix Group-3.46% -2.87% 0.50%
Nakama Group plc (NAK.L) N/A N/A N/A

Nakama Group plc (NAK.L) has lower revenue, but higher earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Nakama Group plc (NAK.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tissue Regenix Group£28.65M0.62-£1.11M-£0.01-2,500.00
Nakama Group plc (NAK.L)£8.09M0.00N/A-£0.20N/A

3.1% of Tissue Regenix Group shares are owned by institutional investors. 6.9% of Tissue Regenix Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Tissue Regenix Group beats Nakama Group plc (NAK.L) on 5 of the 8 factors compared between the two stocks.

Get Tissue Regenix Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRX vs. The Competition

MetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON Exchange
Market Cap£17.81M£236.97M£5.87B£2.58B
Dividend Yield4.12%3.78%5.68%5.30%
P/E Ratio-2,500.0041.0874.525,410.94
Price / Sales0.625,000.68516.2196,691.90
Price / Cash5.7013.1937.5627.93
Price / Book0.60103.7512.167.77
Net Income-£1.11M-£90.99M£3.28B£5.89B
7 Day Performance-16.67%2.70%0.78%6.50%
1 Month Performance-10.71%21.05%4.87%55.93%
1 Year Performance-59.12%530.95%60.72%147.83%

Tissue Regenix Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRX
Tissue Regenix Group
N/AGBX 25
-2.0%
N/A-59.0%£17.81M£28.65M-2,500.00120
NAK
Nakama Group plc (NAK.L)
N/AN/AN/AN/A£1.44M£8.09M-6.1353Gap Down
High Trading Volume
EGI
(EGI.L)
N/AN/AN/AN/A£0.00N/A0.006Gap Down
High Trading Volume
IMG
532753 (IMG.L)
N/AN/AN/AN/A£0.00N/A0.005,360High Trading Volume
EDG
651814 (EDG.L)
N/AN/AN/AN/A£0.00N/A0.002,610
MTA
ArcelorMittal
N/AN/AN/AN/A£0.00N/A0.009High Trading Volume
NGR
Nature Group
N/AN/AN/AN/A£0.00N/A0.0010Gap Up
RRS
Randgold Resources
N/AN/AN/AN/A£0.00N/A0.0021,300Gap Up
NG
National Grid
1.5446 of 5 stars
GBX 1,038
+0.1%
GBX 1,070
+3.1%
-0.4%£50.96B£25.99B17.0510News Coverage
High Trading Volume
WPM
Wheaton Precious Metals
1.1647 of 5 stars
GBX 7,874.99
+0.4%
GBX 8,300
+5.4%
+67.7%£35.75B£1.66B4,536.2842News Coverage
Positive News
Analyst Forecast
Gap Up
IAG
International Consolidated Airlines Group
1.6611 of 5 stars
GBX 382
-0.1%
GBX 403.33
+5.6%
+95.3%£17.67B£33.28B591.335,360

Related Companies and Tools


This page (LON:TRX) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners